TP53 and lung cancer: Recently, using an autophagy loss switchable GEMMs for KrasG12D/+;p53-/- (KP) NSCLC, we demonstrated that transient systemic autophagy ablation is selectively and irreversibly deleterious to lung cancer by impairing lung tumor cell metabolism and promoting T-cell mediated tumor killing [37].